Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

Université Laval

$1,373,175.00

Urethral reconstruction using tissue engineering, final steps towards clinical translation

FY 2024-25

Summary
Urologic patients often present congenital/acquired pathologies requiring surgical reconstruction. Still, it has been challenging due to the limited availability of tissues, especially for the urethra. Therefore, it represents a significant public health issue because nearly 1% of men will suffer from these pathologies, and it has a considerable psychological impact. Interestingly, tissue engineering is a field of research that aims to replace or regenerate these dysfunctional tissues. In urology, bladder reconstruction has been the leading research topic, and we have been part of that endeavor for the last 15 years. We are also interested in urethral tissue engineering, an under-researched field. Through collaborations, a urethral graft was successfully assembled. It became apparent to use this urological tissue as a urethral substitution model. Therefore, we propose to reconstruct a urethral substitute using patient's cells, and free of synthetic material. No other team in Canada is involved in the search for alternatives and we have been leaders in the field of urological tissue engineering for 15 years. In this project, we will evaluate the use of a tissue-engineered graft for urethral reconstruction. The reconstructed urethra should provide better surgical material for correcting complicated congenital anomalies in children. We will test this construct in a rabbit model. The development of urethras reconstructed by tissue engineering would be a significant advance in the field of urology and would have a considerable clinical impact given the complications encountered in clinical practice.
Program
Project Grant
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
507947
Name
Bolduc Stéphane
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Biomedical
Prcname2
Biomedical Engineering 2
Projecttitle
Urethral reconstruction using tissue engineering, final steps towards clinical translation
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$1,373,175
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Animal Model; Bioreactor; Clinical Translation; Fibroblasts; Mechanical Resistance; Self-Assembly Method; Tissue Engineering; Urethra; Urothelial Cells; Xenogen-Free Media
Abstract
Urologic patients often present congenital/acquired pathologies requiring surgical reconstruction. Still, it has been challenging due to the limited availability of tissues, especially for the urethra. Therefore, it represents a significant public health issue because nearly 1% of men will suffer from these pathologies, and it has a considerable psychological impact. Interestingly, tissue engineering is a field of research that aims to replace or regenerate these dysfunctional tissues. In urology, bladder reconstruction has been the leading research topic, and we have been part of that endeavor for the last 15 years. We are also interested in urethral tissue engineering, an under-researched field. Through collaborations, a urethral graft was successfully assembled. It became apparent to use this urological tissue as a urethral substitution model. Therefore, we propose to reconstruct a urethral substitute using patient's cells, and free of synthetic material. No other team in Canada is involved in the search for alternatives and we have been leaders in the field of urological tissue engineering for 15 years. In this project, we will evaluate the use of a tissue-engineered graft for urethral reconstruction. The reconstructed urethra should provide better surgical material for correcting complicated congenital anomalies in children. We will test this construct in a rabbit model. The development of urethras reconstructed by tissue engineering would be a significant advance in the field of urology and would have a considerable clinical impact given the complications encountered in clinical practice.
Competitiondate
202409
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Bolduc, Stéphane
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,373,175~ $0~